StockData
Bio Essence Corp logo

Bio Essence Corp (BIOE) stock

BIOEOTCPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 13, 2026Score 9/30
$0.42+0.03 (+7.72%)

Close on Oct 19, 2026Market cap $22.70MP/E 10.5Yield –

Bio Essence gross margin

Gross margin is gross profit as a percentage of revenue.

Bio Essence's gross margin for the twelve months ending Sep 30, 2026 was 68.4%. For fiscal 2025 it was 75.3%, against 67.0% the year before. The highest annual figure on record is 75.3% in fiscal 2025.

Annual gross margin

PeriodPeriod endValueChange (pts)
FY2025Dec 31, 202575.3%+8.3
FY2024Dec 31, 202467.0%+16.7
FY2023Dec 31, 202350.3%−2.5
FY2022Dec 31, 202252.8%+19.2
FY2021Dec 31, 202133.6%+9.9
FY2020Dec 31, 202023.7%–

Quarterly gross margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q3 FY2026Sep 30, 202655.0%−15.0
Q2 FY2026Jun 30, 202659.2%−5.9
Q1 FY2026Mar 31, 202663.8%−29.0
Q4 FY2025Dec 31, 202577.3%+4.8
Q3 FY2025Sep 30, 202570.0%+9.9
Q2 FY2025Jun 30, 202565.1%−4.9
Q1 FY2025Mar 31, 202592.8%+79.8
Q4 FY2024Dec 31, 202472.4%+30.2
Q3 FY2024Sep 30, 202460.1%+11.3
Q2 FY2024Jun 30, 202470.0%+63.0
Q3 FY2023Sep 30, 202313.0%−32.0
Q2 FY2023Jun 30, 202342.3%−12.4
Q1 FY2023Mar 31, 202348.8%+25.8
Q4 FY2022Dec 31, 20227.0%−21.9
Q3 FY2022Sep 30, 202245.0%+3.0
Q2 FY2022Jun 30, 202254.6%+27.3
Q1 FY2022Mar 31, 202223.0%−13.2
Q4 FY2021Dec 31, 202129.0%+57.3
Q3 FY2021Sep 30, 202142.0%+5.7
Q2 FY2021Jun 30, 202127.3%−2.1
Q1 FY2021Mar 31, 202136.2%−11.5
Q4 FY2020Dec 31, 2020-28.3%–
Q3 FY2020Sep 30, 202036.3%–
Q2 FY2020Jun 30, 202029.4%–
Q1 FY2020Mar 31, 202047.7%–

More Bio Essence figures

See a number that looks wrong?